approval
saveERLEADA (APALUTAMIDE) — FDA approval
community read0 votes
Sponsor: JANSSEN BIOTECH. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalERLEADA (APALUTAMIDE) — FDA approvalMar 5, 2026 · 213d ago
- approvalERLEADA (APALUTAMIDE) — FDA approvalJul 9, 2024 · 817d ago
- approvalERLEADA (APALUTAMIDE) — FDA approvalDec 19, 2023 · 1020d ago
- approvalERLEADA (APALUTAMIDE) — FDA approvalFeb 17, 2023 · 1325d ago
- approvalERLEADA (APALUTAMIDE) — FDA approvalNov 8, 2022 · 1426d ago
- approvalERLEADA (APALUTAMIDE) — FDA approvalNov 8, 2022 · 1426d ago
- approvalERLEADA (APALUTAMIDE) — FDA approvalApr 26, 2022 · 1622d ago
- approvalERLEADA (APALUTAMIDE) — FDA approvalSep 7, 2021 · 1853d ago
same company · ±60 days · 6
- approval(daratumumab + hyaluronidase (human recombinant)): DARZALEX FASPRO (DARATUMUMAB AND HYALURONIDASE-FIHJ) — FDA approvalJul 30, 2024
- approvallazertinib mesylate: LAZCLUZE (LAZERTINIB MESYLATE) — FDA approvalAug 19, 2024
- approvalamivantamab: RYBREVANT (AMIVANTAMAB-VMJW) — FDA approvalAug 19, 2024
- approvalapalutamide: ERLEADA (APALUTAMIDE) — FDA approvalJul 9, 2024
- approvaltalquetamab: TALVEY (TALQUETAMAB-TGVS) — FDA approvalJul 2, 2024
- approvalteclistamab: TECVAYLI (TECLISTAMAB-CQYV) — FDA approvalJul 2, 2024
comments(0)
5-min edit window · permanent after that